Editor's pick of the month:

January, 2009

“Are we protected from ‘IT’?  is the question on everybody’s mind, as the New Year dawns.  The ‘IT’ is the global recession and it is playing in the minds of big pharmaceutical company directors as much as much as in the minds of academia looking for funds or small companies surviving on ‘outsourcing’.  So much so that ‘Nature’ has dedicated a special section on ‘Recession watch’!  The experts’ opinion borders more on hope that the pharma sector will survive, if not ‘’flourish’.  In India, the outlook is not so bad, as Malvinder Singh of Ranbaxy Laboratories asserts; an analysis in ExpressPharma also backs this up with views from various stalwarts in the pharma sector.  Elsewhere, there is caution in health care and pharma sector.  An Ernst & Young report calls for quick implementation of transformational plans.  Pipeline issues are a concern.  As we usher in the New Year, we can only wait and watch, and hope that we tide over this global crisis without compromising on the research and development in science, including QSAR!”   To read all articles previously featured under 'Editor's pick of the month' please click here  Editor's pick archives